MEC Basic Full List ViewBy pinki@katapult.biz / February 16, 2025 MEC Basic Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignant Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Oral Cancer Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title Type of Media — Video Document Audio Events — 2024 California Cancer Consortium Conference (CCC) 2024 MCM 2024 MCM 2024 MLS Cleveland 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 WCS 2024 MaTOS Lungs 2025 PRIMO Search Everything « 1 … 5 6 7 8 9 … 62 » Renal Cell Carcinoma Updates Scott Tykodi, MD View PDF ASCO GI 2024 Updates David B. Zhen, MD View PDF Head and Neck Cancer 2024 Updates Cristina P. Rodriguez, MD View PDF HER2 Targeted Therapies: Recent Advances Helen Chew, MD, FACP View PDF New Biomarkers in Breast Cancer Joanne Mortimer, MD, FACP, FASCO View PDF Immunotherapy for Breast Cancer: When to Use and Future Directions Evanthia Torres, MD, PhD View PDF Hormone Therapy in Breast Cancer: New Directions Mili Arora, MD View PDF Targeting the Microbiome and Optimizing Immunotherapy in Cancer Sumanta K. Pal, MD, FASCO View PDF Targeting RAS-RAF-MAPK Pathway Jacob Thomas, MD View PDF Hippo-Yap Pathway Janai Carr-Ascher, MD, PhD View PDF Novel Targets in Hematologic Malignancies Tycel Phillips, MD View PDF Lymphoma: State of the Art Alexey Danilov, MD, PhD View PDF AML and MDS: New Directions Olatoyosi Odenike, MD View PDF Systemic Therapy in Urothelial Carcinoma Sarmad Sadeghi, MD, PhD View PDF Management of Renal Cell Carcinoma Shuchi Gulati, MD, MS, FACP View PDF Castration Resistant Prostate Cancer: What is the Optimal Strategy? Mamta Parikh, MD, MS View PDF State of the Art: Hormone-sensitive Prostate Cancer Abhishek Tripathi, MD View PDF Precision Oncology and Landmark Advances in GU Malignancies Walter M. Stadler, MD, FACP View PDF Updates in Locally Advanced Unresectable (Stage III) NSCLC Jorge Nieva, MD View PDF Advances in Limited and Extensive Stage Small Cell Lung Cancer Jyoti Malhotra, MD, MPH View PDF Updates in NSCLC Targeted Therapy Jonathan W. Riess, MD, MS View PDF Updates in Immunotherapy for Metastatic Lung Cancer Erminia Massarelli, MD, PhD, MS View PDF New Developments in Esophageal and Gastric Cancer Sandra Algaze, MD View PDF Recent Advances in Colorectal Cancer Heinz-Josef Lenz, MD, FACP View PDF Updates in the Management of Pancreatic Cancer Vincent Chung, MD, FACP View PDF Advances in Cellular Therapies for Cancer Mohamed Abou-el-Enein, MD, PhD, MSPH View PDF Advances in Non-PD(L)1 Immunotherapies in Solid Tumors Miguel Villalona-Calero, MD View PDF Perioperative Therapy and Predictive Biomarkers in Early Stage Non Small Cell Lung Cancer David Gandara, MD View PDF Overview on How to Submit a Clinical Letter of Intent (LOI) to NCI/CTEP S. Percy Ivy, MD View PDF Expansion Cohorts in Early Phase Clinical Trials: Valuable or Not? Paul Frankel, PhD View PDF
